company background image
MITRA logo

Mithra Pharmaceuticals ENXTBR:MITRA 株式レポート

最終価格

€0.22

時価総額

€12.1m

7D

0%

1Y

-90.1%

更新

20 Sep, 2024

データ

会社財務 +

Mithra Pharmaceuticals SA

ENXTBR:MITRA 株式レポート

時価総額:€12.1m

This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

MITRA 株式概要

Mithra Pharmaceuticals SA社は、避妊、更年期障害、ホルモン依存性癌の分野における複合的治療薬をベルギー、ヨーロッパ、および国際的に開発、製造、販売している。 詳細

MITRA ファンダメンタル分析
スノーフレーク・スコア
評価3/6
将来の成長5/6
過去の実績0/6
財務の健全性1/6
配当金0/6

Mithra Pharmaceuticals SA 競合他社

価格と性能

の歴代最高値、変動、値下がりまとめMithra Pharmaceuticals
過去の株価
現在の株価€0.22
52週高値€2.29
52週安値€0.20
ベータ0.51
11ヶ月の変化0%
3ヶ月変化0%
1年変化-90.11%
33年間の変化-98.79%
5年間の変化-99.27%
IPOからの変化-98.19%

最新ニュース

Not Many Are Piling Into Mithra Pharmaceuticals SA (EBR:MITRA) Stock Yet As It Plummets 26%

Apr 06
Not Many Are Piling Into Mithra Pharmaceuticals SA (EBR:MITRA) Stock Yet As It Plummets 26%

Recent updates

Not Many Are Piling Into Mithra Pharmaceuticals SA (EBR:MITRA) Stock Yet As It Plummets 26%

Apr 06
Not Many Are Piling Into Mithra Pharmaceuticals SA (EBR:MITRA) Stock Yet As It Plummets 26%

Revenues Working Against Mithra Pharmaceuticals SA's (EBR:MITRA) Share Price Following 39% Dive

Feb 07
Revenues Working Against Mithra Pharmaceuticals SA's (EBR:MITRA) Share Price Following 39% Dive

Party Time: Brokers Just Made Major Increases To Their Mithra Pharmaceuticals SA (EBR:MITRA) Earnings Forecasts

Nov 09
Party Time: Brokers Just Made Major Increases To Their Mithra Pharmaceuticals SA (EBR:MITRA) Earnings Forecasts

These Analysts Just Made A Huge Downgrade To Their Mithra Pharmaceuticals SA (EBR:MITRA) EPS Forecasts

Oct 05
These Analysts Just Made A Huge Downgrade To Their Mithra Pharmaceuticals SA (EBR:MITRA) EPS Forecasts

Take Care Before Diving Into The Deep End On Mithra Pharmaceuticals SA (EBR:MITRA)

May 23
Take Care Before Diving Into The Deep End On Mithra Pharmaceuticals SA (EBR:MITRA)

Bullish: Analysts Just Made A Huge Upgrade To Their Mithra Pharmaceuticals SA (EBR:MITRA) Forecasts

Aug 11
Bullish: Analysts Just Made A Huge Upgrade To Their Mithra Pharmaceuticals SA (EBR:MITRA) Forecasts

Growth Investors: Industry Analysts Just Upgraded Their Mithra Pharmaceuticals SA (EBR:MITRA) Revenue Forecasts By 21%

Mar 13
Growth Investors: Industry Analysts Just Upgraded Their Mithra Pharmaceuticals SA (EBR:MITRA) Revenue Forecasts By 21%

Mithra Pharmaceuticals (EBR:MITRA) Is Making Moderate Use Of Debt

Dec 22
Mithra Pharmaceuticals (EBR:MITRA) Is Making Moderate Use Of Debt

Some Mithra Pharmaceuticals SA (EBR:MITRA) Analysts Just Made A Major Cut To Next Year's Estimates

Nov 24
Some Mithra Pharmaceuticals SA (EBR:MITRA) Analysts Just Made A Major Cut To Next Year's Estimates

Here's Why Mithra Pharmaceuticals (EBR:MITRA) Can Afford Some Debt

Jun 07
Here's Why Mithra Pharmaceuticals (EBR:MITRA) Can Afford Some Debt

When Will Mithra Pharmaceuticals SA (EBR:MITRA) Turn A Profit?

May 10
When Will Mithra Pharmaceuticals SA (EBR:MITRA) Turn A Profit?

Is Mithra Pharmaceuticals SA's (EBR:MITRA) Shareholder Ownership Skewed Towards Insiders?

Mar 18
Is Mithra Pharmaceuticals SA's (EBR:MITRA) Shareholder Ownership Skewed Towards Insiders?

We're Not So Sure You Should Rely on Mithra Pharmaceuticals' (EBR:MITRA) Statutory Earnings

Feb 16
We're Not So Sure You Should Rely on Mithra Pharmaceuticals' (EBR:MITRA) Statutory Earnings

Analysts Expect Breakeven For Mithra Pharmaceuticals SA (EBR:MITRA) Before Long

Jan 21
Analysts Expect Breakeven For Mithra Pharmaceuticals SA (EBR:MITRA) Before Long

Some Mithra Pharmaceuticals SA (EBR:MITRA) Analysts Just Made A Major Cut To Next Year's Estimates

Nov 29
Some Mithra Pharmaceuticals SA (EBR:MITRA) Analysts Just Made A Major Cut To Next Year's Estimates

株主還元

MITRABE PharmaceuticalsBE 市場
7D0%2.7%0.6%
1Y-90.1%8.0%3.5%

業界別リターン: MITRA過去 1 年間で8 % の収益を上げたBelgian Pharmaceuticals業界を下回りました。

リターン対市場: MITRAは、過去 1 年間で3.5 % のリターンを上げたBelgian市場を下回りました。

価格変動

Is MITRA's price volatile compared to industry and market?
MITRA volatility
MITRA Average Weekly Movement0%
Pharmaceuticals Industry Average Movement5.3%
Market Average Movement3.4%
10% most volatile stocks in BE Market6.3%
10% least volatile stocks in BE Market2.4%

安定した株価: MITRA過去 3 か月間に大きな価格変動はありませんでした。

時間の経過による変動: 過去 1 年間のMITRAのボラティリティの変化を判断するには データが不十分です

会社概要

設立従業員CEO(最高経営責任者ウェブサイト
1999270Christophe Marechalwww.mithra.com

ミトラ・ファーマシューティカルズSAは、避妊、更年期障害、ホルモン依存性癌の分野における複合治療薬をベルギー、ヨーロッパおよび国際的に開発、製造、販売している。同社の開発候補品には、第III相臨床試験を完了した経口避妊薬配合剤Estelle、エステトロールベースの経口ホルモン治療薬として第III相臨床試験中のDonesta、神経保護および創傷治癒のための製品などがある。また、複合ホルモンを放出する避妊用膣リング「マイリング」、更年期のホルモン療法に使用されるチボロンと合成ステロイドからなる錠剤「チベリア」、前立腺がんや乳がん、良性の婦人科疾患に使用される生分解性皮下インプラント「ゾレリン」なども開発している。さらに、ポリマー製剤、インプラント、無菌注射剤、ホルモン錠剤の製品も提供している。同社は1999年に設立され、ベルギーのリエージュに本社を置いている。

Mithra Pharmaceuticals SA 基礎のまとめ

Mithra Pharmaceuticals の収益と売上を時価総額と比較するとどうか。
MITRA 基礎統計学
時価総額€12.14m
収益(TTM)-€173.50m
売上高(TTM)€40.16m

0.4x

P/Sレシオ

-0.1x

PER(株価収益率

収益と収入

最新の決算報告書(TTM)に基づく主な収益性統計
MITRA 損益計算書(TTM)
収益€40.16m
売上原価€21.95m
売上総利益€18.21m
その他の費用€191.71m
収益-€173.50m

直近の収益報告

Dec 31, 2023

次回決算日

Sep 26, 2024

一株当たり利益(EPS)-2.51
グロス・マージン45.34%
純利益率-432.08%
有利子負債/自己資本比率-258.9%

MITRA の長期的なパフォーマンスは?

過去の実績と比較を見る